StonvexLoading…
StonvexStonvexStonvexCore line items from STLA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | €153.51B | €156.88B | €189.54B | €179.59B |
Operating Income | €-26.25B | €3.69B | €22.38B | €20.28B |
Net Income | €-22.33B | €5.52B | €18.63B | €16.78B |
EPS (Diluted) | €-7.75 | €1.84 | €5.94 | €5.31 |
Total Assets | €195.15B | €207.61B | €202.13B | €186.16B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | €30.15B | €34.10B | €43.67B | €46.43B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 3.76B | 3.75B | 3.02B | 3.14B |